Which anticholinergic is commonly used in preanesthetic protocols to prevent bradycardia and to treat organophosphate toxicity?

Which anticholinergic is commonly used in preanesthetic protocols to prevent bradycardia and to treat organophosphate toxicity?

• A. Glycopyrrolate
• B. Atropine
• C. Pilocarpine
• D. Physostigmine

Answer: (B)

Excess acetylcholine at muscarinic receptors drives bradycardia and secretions in organophosphate poisoning, and blocking these receptors prevents those effects. Atropine is a competitive muscarinic antagonist that acts quickly when given IV, making it ideal for both stopping anesthetic-induced bradycardia and reversing the muscarinic signs of organophosphate toxicity. While other anticholinergics like glycopyrrolate can prevent bradycardia, atropine is the classic choice for organophosphate poisoning due to its rapid onset and ability to counteract the muscarinic crisis. Pilocarpine is a muscarinic agonist and would worsen symptoms, and physostigmine inhibits acetylcholinesterase (increasing acetylcholine) and is used for anticholinergic toxicity, not for preventing bradycardia or treating organophosphate poisoning.

Excess acetylcholine at muscarinic receptors drives bradycardia and secretions in organophosphate poisoning, and blocking these receptors prevents those effects. Atropine is a competitive muscarinic antagonist that acts quickly when given IV, making it ideal for both stopping anesthetic-induced bradycardia and reversing the muscarinic signs of organophosphate toxicity. While other anticholinergics like glycopyrrolate can prevent bradycardia, atropine is the classic choice for organophosphate poisoning due to its rapid onset and ability to counteract the muscarinic crisis. Pilocarpine is a muscarinic agonist and would worsen symptoms, and physostigmine inhibits acetylcholinesterase (increasing acetylcholine) and is used for anticholinergic toxicity, not for preventing bradycardia or treating organophosphate poisoning.